Cerecin
PrivateLast Round
Pre Seed
May 9, 2024
Total Funding Raised
$46M
Company Overview
Cerecin is a clinical-stage biotechnology company that develops therapeutics targeting the metabolic basis of central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Imaging
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cerecin Comparables
Compare Cerecin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| T3D Therapeutics, Inc. | 78% | |
| AriBio | 70% | |
| Nestlé | 64% | |
Cerecin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 9, 2024 | ||||
| Series B Extension | Oct 3, 2022 | ||||
| Series B | Oct 19, 2021 | ||||
| VC Round | Oct 4, 2018 | ||||
| VC Round | Jul 18, 2012 | ||||
Series A | Oct 5, 2004 |
Cerecin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wilmar Ventures | Pre Seed, VC Round |
| Hanwha Investment & Securities | Pre Seed |
| BNK Securities | Pre Seed |
| Linea Investment | Series A |
| IBK Capital | Series B |
| KNT Investment | Series B Extension |
| KB Securities | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 9, 2024
$29M round with participation from Nestlé and Wilmar Ventures.
- Oct 3, 2022
Led by SK Securities and KNT Investment.
Cerecin Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cerecin's valuation, stock price, and market status.